BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 15507782)

  • 1. Functional impairment of simian immunodeficiency virus-specific CD8+ T cells during the chronic phase of infection.
    Vogel TU; Allen TM; Altman JD; Watkins DI
    J Virol; 2001 Mar; 75(5):2458-61. PubMed ID: 11160749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic dendritic-cell vaccine for simian AIDS.
    Lu W; Wu X; Lu Y; Guo W; Andrieu JM
    Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
    Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
    Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.
    Kawada M; Igarashi H; Takeda A; Tsukamoto T; Yamamoto H; Dohki S; Takiguchi M; Matano T
    J Virol; 2006 Feb; 80(4):1949-58. PubMed ID: 16439550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag.
    Melhem NM; Liu XD; Boczkowski D; Gilboa E; Barratt-Boyes SM
    Eur J Immunol; 2007 Aug; 37(8):2164-73. PubMed ID: 17615585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses.
    Couillin I; Letourneur F; Lefèbvre P; Guillet JG; Martinon F
    Virology; 2001 Jan; 279(1):136-45. PubMed ID: 11145897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of virus-specific T cell responses by dendritic cell vaccination in the chronic phase of simian AIDS models.
    Kato M; Igarashi H; Takeda A; Horie S; Higashihara E; Matano T
    Jpn J Infect Dis; 2004 Oct; 57(5):220-3. PubMed ID: 15507782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8(+) T cells in preventing HIV infection and disease.
    McDermott AB; Koup RA
    AIDS; 2012 Jun; 26(10):1281-92. PubMed ID: 22441256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model.
    Barratt-Boyes SM; Brown KN; Melhem N; Soloff AC; Gleason SM
    Immunol Res; 2006; 36(1-3):265-74. PubMed ID: 17337787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic Cells in HIV/SIV Prophylactic and Therapeutic Vaccination.
    Ko EJ; Robert-Guroff M
    Viruses; 2019 Dec; 12(1):. PubMed ID: 31878130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms behind the immune response induced by immunostimulating complexes.
    Morein B; Villacrés Eriksson M; Akerblom L; Rönnberg B; Lövgren K; Sjölander A
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S109-14. PubMed ID: 7865283
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaccination, the end?].
    Schouten MC; Overgaauw PA
    Tijdschr Diergeneeskd; 2001 Apr; 126(7):256-7. PubMed ID: 11310260
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.